Welch Group, LLC reports 3.26% increase in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Welch Group, LLC
Latest Disclosed Ownership	12,093 shares
Latest Disclosed Value	$ 733,471

On April 21, 2026 - Welch Group, LLC filed a 13F-HR form disclosing ownership of 12,093 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $633,915 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 11,711 shares of Bristol-Myers Squibb Company. This represents a change in shares of 3.26% during the quarter. The current value of the position is $573,571 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-04-21	2026-03-31	13F	BRISTOL-MYERS SQUIBB	COMMON	110122108	12,093	382	3.26	733	16.16	0.0276
2026-01-26	2025-12-31	13F	BRISTOL-MYERS SQUIBB	COMMON STOCK	110122108	11,711	720	6.55	632	27.47	0.0244
2025-10-14	2025-09-30	13F	BRISTOL-MYERS SQUIBB	COMMON	110122108	10,991	673	6.52	496	3.77	0.0194
2025-07-25	2025-06-30	13F	BRISTOL-MYERS SQUIBB	COMMON	110122108	10,318	108	1.06	478	-22.06	0.0200
2025-04-08	2025-03-31	13F	BRISTOL-MYERS SQUIBB	COMMON	110122108	10,210	-1,669	-14.05	613	-7.97	0.0270
2025-01-27	2024-12-31	13F	BRISTOL-MYERS SQUIBB	COMMON	110122108	11,879	-1,005	-7.80	666	-0.15	0.0300
2024-10-24	2024-09-30	13F	BRISTOL-MYERS SQUIBB	COMMON	110122108	12,884	-3,453	-21.14	667	-1.77	0.0290
2024-07-17	2024-06-30	13F	BRISTOL-MYERS SQUIBB	COMMON	110122108	16,337	-345	-2.07	678	-25.00	0.0326
2024-04-09	2024-03-31	13F	BRISTOL-MYERS SQUIBB	COMMON	110122108	16,682	-66,868	-80.03	905	-78.91	0.0449
2024-01-23	2023-12-31	13F	BRISTOL-MYERS SQUIBB	Common	110122108	83,550	-4,323	-4.92	4,287	-15.96	0.2309
2023-10-18	2023-09-30	13F	BRISTOL-MYERS SQUIBB	Common	110122108	87,873	3,757	4.47	5,100	-5.19	0.3022
2023-07-18	2023-06-30	13F	BRISTOL-MYERS SQUIBB	Common	110122108	84,116	4,955	6.26	5,379	-1.95	0.3084
2023-04-13	2023-03-31	13F	BRISTOL-MYERS SQUIBB	Common	110122108	79,161	3,655	4.84	5,487	0.99	0.3190
2023-01-30	2022-12-31	13F	BRISTOL-MYERS SQUIBB	Common	110122108	75,506	1,964	2.67	5,433	3.90	0.3108
2022-10-13	2022-09-30	13F	BRISTOL-MYERS SQUIBB	COMMON	110122108	73,542	801	1.10	5,228	-6.66	0.3403
2022-07-21	2022-06-30	13F	BRISTOL-MYERS SQUIBB	COMMON	110122108	72,741	1,001	1.40	5,601	6.91	0.3418
2022-04-29	2022-03-31	13F	BRISTOL-MYERS SQUIBB	COMMON	110122108	71,740	9,257	14.82	5,239	34.47	0.2991
2022-01-26	2021-12-31	13F	BRISTOL-MYERS SQUIBB	COMMON	110122108	62,483	3,738	6.36	3,896	12.08	0.2279
2021-11-05	2021-09-30	13F	BRISTOL-MYERS SQUIBB	COMMON	110122108	58,745	8,216	16.26	3,476	2.96	0.2353
2021-07-21	2021-06-30	13F	BRISTOL-MYERS SQUIBB	COMMON	110122108	50,529	4,514	9.81	3,376	16.21	0.2302
2021-04-23	2021-03-31	13F	BRISTOL-MYERS SQUIBB	COMMON	110122108	46,015	12,849	38.74	2,905	41.23	0.2091
2021-01-25	2020-12-31	13F	BRISTOL-MYERS SQUIBB	Common	110122108	33,166	2,453	7.99	2,057	11.07	0.1650
2020-10-28	2020-09-30	13F	BRISTOL-MYERS SQUIBB	Common	110122108	30,713	5,704	22.81	1,852	25.90	0.1618
2020-07-22	2020-06-30	13F	BRISTOL-MYERS SQUIBB	Common	110122108	25,009	1,227	5.16	1,471	10.94	0.1374
2020-04-28	2020-03-31	13F	BRISTOL-MYERS SQUIBB	Common	110122108	23,782	9,626	68.00	1,326	45.87	0.1415
2020-01-24	2019-12-31	13F	Bristol-Myers Squibb	Common	110122108	14,156	3,308	30.49	909	65.27	0.0894
2019-11-05	2019-09-30	13F	Bristol-Myers Squibb	Common	110122108	10,848	467	4.50	550	16.77	0.0565
2019-07-11	2019-06-30	13F	Bristol-Myers Squibb	Common	110122108	10,381	-695	-6.27	471	-10.80	0.0503
2019-04-15	2019-03-31	13F	Bristol-Myers Squibb	Common	110122108	11,076	0	0.00	528	-8.33	0.0581
2019-01-10	2018-12-31	13F	Bristol-Myers Squibb	Common	110122108	11,076	-200	-1.77	576	-17.71	0.0706
2018-11-01	2018-09-30	13F	Bristol-Myers Squibb	Common	110122108	11,276	0	0.00	700	12.18	0.0729
2018-07-30	2018-06-30	13F	Bristol-Myers Squibb	Common	110122108	11,276	46	0.41	624	-12.11	0.0777
2018-04-23	2018-03-31	13F	Bristol-Myers Squibb	Common	110122108	11,230	2,153	23.72	710	27.70	0.0899
2018-02-01	2017-12-31	13F	Bristol-Myers Squibb	Common	110122108	9,077	-468	-4.90	556	80.52	0.0862
2017-11-07	2017-09-30	13F	Bristol-Myers Squibb	Common	110122108	9,545	300	3.24	308	-40.19	0.0515
2017-08-07	2017-06-30	13F	Bristol-Myers Squibb	Common	110122108	9,245	-330	-3.45	515	-1.15	0.0859
2017-05-01	2017-03-31	13F	Bristol-Myers Squibb	Common	110122108	9,575	-9	-0.09	521	-6.96	0.0981
2017-02-09	2016-12-31	13F	Bristol-Myers Squibb	Common	110122108	9,584	0	0.00	560	8.32	0.1095
2016-10-28	2016-09-30	13F	Bristol-Myers Squibb	Common	110122108	9,584	2,100	28.06	517	-6.00	0.1027
2016-07-27	2016-06-30	13F	Bristol-Myers Squibb	Common	110122108	7,484	-940	-11.16	550	2.23	0.1120
2016-05-05	2016-03-31	13F	Bristol-Myers Squibb	Common	110122108	8,424	0	0.00	538	-7.08	0.0898
2016-01-21	2015-12-31	13F	Bristol-Myers Squibb	Common	110122108	8,424	30	0.36	579	16.50	0.1040
2015-10-23	2015-09-30	13F	Bristol-Myers Squibb	COM	110122108	8,394	1,000	13.52	497	1.02	0.0961
2015-07-31	2015-06-30	13F	Bristol-Myers Squibb	Common	110122108	7,394	0	0.00	492	3.14	0.0931
2015-04-29	2015-03-31	13F	Bristol-Myers Squibb	Common	110122108	7,394	-300	-3.90	477	5.07	0.0876
2015-01-20	2014-12-31	13F	Bristol-Myers Squibb	Common	110122108	7,694	-4	-0.05	454	15.23	0.0876
2014-10-29	2014-09-30	13F	Bristol-Myers Squibb	Common	110122108	7,698	0	0.00	394	5.63	0.0814
2014-07-22	2014-06-30	13F	Bristol-Myers Squibb	Common	110122108	7,698	0	0.00	373	-6.75	0.0772
2014-04-23	2014-03-31	13F	Bristol-Myers Squibb	COM	110122108	7,698	-496	-6.05	400	-8.26	0.0906
2014-02-07	2013-12-31	13F	Bristol-Myers Squibb	Common	110122108	8,194	1,510	22.59	436	41.10	0.0988
2013-10-04	2013-09-30	13F	Bristol-Myers Squibb	Common	110122108	6,684	0	0.00	309	3.34	0.0760
2013-07-29	2013-06-30	13F	Bristol-Myers Squibb	Common	110122108	6,684	6,684		299		0.0776

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.